JC Chemical Balance Sheet Health
Financial Health criteria checks 5/6
JC Chemical has a total shareholder equity of ₩160.7B and total debt of ₩106.4B, which brings its debt-to-equity ratio to 66.2%. Its total assets and total liabilities are ₩300.1B and ₩139.4B respectively. JC Chemical's EBIT is ₩32.1B making its interest coverage ratio 8.1. It has cash and short-term investments of ₩21.1B.
Key information
66.2%
Debt to equity ratio
₩106.42b
Debt
Interest coverage ratio | 8.1x |
Cash | ₩21.06b |
Equity | ₩160.73b |
Total liabilities | ₩139.41b |
Total assets | ₩300.14b |
Recent financial health updates
We Think JC Chemical (KOSDAQ:137950) Is Taking Some Risk With Its Debt
Apr 05Here's Why JC Chemical (KOSDAQ:137950) Has A Meaningful Debt Burden
Dec 30Recent updates
We Think JC Chemical (KOSDAQ:137950) Is Taking Some Risk With Its Debt
Apr 05Could The JC Chemical Co., Ltd. (KOSDAQ:137950) Ownership Structure Tell Us Something Useful?
Mar 19Returns On Capital - An Important Metric For JC Chemical (KOSDAQ:137950)
Mar 03Is JC Chemical's (KOSDAQ:137950) 106% Share Price Increase Well Justified?
Feb 16A Note On JC Chemical Co., Ltd.'s (KOSDAQ:137950) ROE and Debt To Equity
Feb 01Is JC Chemical Co., Ltd. (KOSDAQ:137950) A Smart Pick For Income Investors?
Jan 14Here's Why JC Chemical (KOSDAQ:137950) Has A Meaningful Debt Burden
Dec 30Could The JC Chemical Co., Ltd. (KOSDAQ:137950) Ownership Structure Tell Us Something Useful?
Dec 15Will JC Chemical's (KOSDAQ:137950) Growth In ROCE Persist?
Nov 30Financial Position Analysis
Short Term Liabilities: A137950's short term assets (₩117.9B) exceed its short term liabilities (₩109.0B).
Long Term Liabilities: A137950's short term assets (₩117.9B) exceed its long term liabilities (₩30.4B).
Debt to Equity History and Analysis
Debt Level: A137950's net debt to equity ratio (53.1%) is considered high.
Reducing Debt: A137950's debt to equity ratio has reduced from 122.7% to 66.2% over the past 5 years.
Debt Coverage: A137950's debt is well covered by operating cash flow (44%).
Interest Coverage: A137950's interest payments on its debt are well covered by EBIT (8.1x coverage).